COSMOS Pharmaceutical Corporation
Notice of Director Candidate Decision and Executive Changes
Decides on director candidates and discloses the names, appointments, and resignations of director candidates. Background information on the new candidate is provided, with formal decisions expected at the 44th ordinary general meeting of shareholders to be held on August 28, 2026.
Key Figures
- New director candidate: Motoki Takemori
- Resigning director: Ta Shibata
- Background of the new candidate: since 1994, positions held (current: Head of Corporate Planning)
AI要約
Decision on director candidates and the upcoming approval process
At today's board meeting, director candidates including President and Representative Director Hideaki Yokoyama were decided, and after the candidates are approved at the 44th Ordinary General Meeting of Shareholders scheduled for August 28, 2026, they will be formally decided at the board meeting scheduled for the same day. The new candidate is Motoki Takemori, currently Head of Corporate Planning. Shiro Uno is Head of Finance and Accounting. The resignations include Ta Shibata, resigning from the Legal Affairs Department.
Background of the new candidate and future personnel trends
Motoki Takemori has been with the company since 1994, progressing through roles including Sales Department Product Manager, Product Director, Director of Product, Director of Sales Planning, Store Development Manager, and Head of Finance and Accounting, and is expected to continue in his current role as Head of Corporate Planning as the new director candidate.
Cosmos Pharmaceutical
Company overview · Stock price · Financial data · All IR
